Biomarker development in the precision medicine era: lung cancer as a case study

被引：407

作者：

Vargas, Ashley J. ^{[1
,2
]}

Harris, Curtis C. ^{[1
]}

机构：

[1] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Room 3068A,MSC 425,837 Convent Dr, Bethesda, MD 20892 USA

[2] NCI, Canc Prevent Div, Rockville, MD 20850 USA

来源：

NATURE REVIEWS CANCER | 2016年 / 16卷 / 08期

关键词：

C-REACTIVE PROTEIN; REPORTING RECOMMENDATIONS; GENE-EXPRESSION; INTERNATIONAL-ASSOCIATION; PROGNOSTIC CLASSIFIER; COMPANION DIAGNOSTICS; AFRICAN-AMERICANS; EGFR MUTATIONS; MESSENGER-RNA; NEVER SMOKERS;

D O I：

10.1038/nrc.2016.56

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Precision medicine relies on validated biomarkers with which to better classify patients by their probable disease risk, prognosis and/or response to treatment. Although affordable 'omics'-based technology has enabled faster identification of putative biomarkers, the validation of biomarkers is still stymied by low statistical power and poor reproducibility of results. This Review summarizes the successes and challenges of using different types of molecule as biomarkers, using lung cancer as a key illustrative example. Efforts at the national level of several countries to tie molecular measurement of samples to patient data via electronic medical records are the future of precision medicine research.

引用

页码：525 / 537

页数：13

共 50 条

[31] Cell death in cancer in the era of precision medicine
Giuseppe Raschellà
Gerry Melino
Alessandra Gambacurta
Genes & Immunity, 2019, 20 : 529 - 538
[32] Cell death in cancer in the era of precision medicine
Raschella, Giuseppe
Melino, Gerry
Gambacurta, Alessandra
GENES AND IMMUNITY, 2019, 20 (07) : 529 - 538
[33] A New Era of Prostate Cancer Precision Medicine
Malik, Adil
Srinivasan, Sri
Batra, Jyotsna
FRONTIERS IN ONCOLOGY, 2019, 9
[34] Breast Cancer Prevention in the Era of Precision Medicine
Narod, Steven A.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (05):
[35] Implementing precision cancer medicine in the genomic era
Chen, Hui-Zi
Bonneville, Russell
Roychowdhury, Sameek
SEMINARS IN CANCER BIOLOGY, 2019, 55 : 16 - 27
[36] Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review
Maekawa, Shigekatsu
Takata, Ryo
Obara, Wataru
CANCERS, 2024, 16 (03)
[37] PD-L1 and Lung Cancer The Era of Precision-ish Medicine?
Borczuk, Alain C.
Allen, Timothy Craig
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (04) : 351 - 354
[38] Predictive biomarkers in precision medicine and drug development against lung cancer
Fang, Bingliang
Mehran, Reza J.
Heymach, John V.
Swisher, Stephen G.
CHINESE JOURNAL OF CANCER, 2015, 34
[39] Radiomics in precision medicine for lung cancer
Constanzo, Julie
Wei, Lise
Tseng, Huan-Hsin
El Naqa, Issam
TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (06) : 635 - 647
[40] A Case of Lung Cancer: Precision Medicine and Patient-Centered Approach
Casablanca, N. N. Munoz
Baharlou, S.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 70 : S18 - S18

← 1 2 3 4 5 →